Krüppel-Like Factor 4 Inhibits Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis by Down-Regulating Caveolin-1 Expression

• Published in: Cellular physiology and biochemistry Vol. 46; no. 1; pp. 238 - 252
• Main Authors: Zhu, Zhonglin, Yu, Zhilong, Wang, Jianfeng, Zhou, Lisheng, Zhang, Jing, Yao, Bin, Dou, Jin, Qiu, Zhengjun, Huang, Chen
• Format: Journal Article
• Language: English
• Published: Basel, Switzerland S. Karger AG 01.01.2018; Cell Physiol Biochem Press GmbH & Co KG
• Subjects: Animals; Base Sequence; Biotechnology; Breast cancer; Cadherins - metabolism; Caveolin 1 - genetics; Caveolin 1 - metabolism; Caveolin-1; Cell growth; Cell Line; Cell Movement; Databases, Factual; Down-Regulation; Epithelial-Mesenchymal Transition; Epithelial-to-mesenchymal transition; Gastric cancer; Gene expression; Humans; Klf4; Kruppel-Like Transcription Factors - antagonists & inhibitors; Kruppel-Like Transcription Factors - genetics; Kruppel-Like Transcription Factors - metabolism; Liver cancer; Medical prognosis; Metastasis; Mice; Mice, Nude; Morphology; Neoplasm Metastasis; Neoplasm Staging; Original Paper; Pancreatic cancer; Pancreatic Neoplasms - drug therapy; Pancreatic Neoplasms - metabolism; Pancreatic Neoplasms - pathology; Promoter Regions, Genetic; Protein Binding; Proteins; RNA Interference; RNA, Small Interfering - metabolism; RNA, Small Interfering - therapeutic use; Transplantation, Heterologous; Vimentin - metabolism; United States > US; Caveolin-1; Metastasis; Klf4; Pancreatic cancer; Epithelial-to-mesenchymal transition
• ISSN: 1015-8987; 1421-9778
• DOI: 10.1159/000488426

Background/Aims: Krüppel-like factor 4 (KLF4), a member of the KLF family of zinc finger transcription factors, has been identified as a tumor suppressor gene in a variety of tumors. However, the molecular mechanisms by which KLF4 inhibits epithelial-to-mesenchymal transition (EMT) and metastasis in pancreatic cancer remain unclear. Methods: KLF4 expression in pancreatic cancer was analyzed using public datasets (Oncomine and The Cancer Genome Atlas). The expression of KLF4, caveolin-1 (Cav-1), E-cadherin, and vimentin, and their correlations with clinicopathological characteristics were evaluated by immunohistochemistry in pancreatic cancer tissues. The biological functions and underlying mechanisms of KLF4 expression on EMT and metastasis were also investigated in vitro and in vivo. Results: Public datasets showed that KLF4 expression was significantly decreased in pancreatic cancer and correlated with the depth of invasion and disease stage. The expression of KLF4, Cav-1, E-cadherin, and vimentin protein in pancreatic cancer tissues was closely associated with pathological grade, disease stage, and metastasis. KLF4 expression was also positively correlated with E-cadherin expression and negatively correlated with vimentin expression, whereas Cav-1 expression was negatively associated with E-cadherin expression and positively correlated with vimentin expression. Knockdown of KLF4 expression promoted EMT and facilitated pancreatic cancer cell growth and metastasis in vitro and in vivo. In addition, immunohistochemistry (IHC) results indicated that KLF4 expression was negatively correlated with Cav-1 expression. Furthermore, down-regulating KLF4 expression increased Cav-1 and vimentin expression and decreased E-cadherin expression. Mechanistically, KLF4 could transcriptionally inhibit Cav-1 expression by binding directly to the promoter domain of Cav-1. Conclusions: KLF4 inhibits pancreatic cancer EMT and metastasis by down-regulating Cav-1 expression, suggesting that the KLF4/Cav-1 signaling pathway may be a novel diagnostic and therapeutic target.